185
δ 5.22 (d, 1H, J1,2 = 9.1 Hz, H-1), 4.93 (t, 1H, J2,3 = 8.4 Hz, H- m/z 575.1 (M+ + H, C16H22HgO8S, Calcd 575.0). Anal. Calcd
2), 5.13 (t, 1H, J3,4 = 8.4 Hz, H-3), 4.86 (ddd, 1H, J4,5a = 7.7 Hz, for C16H22HgO8S: C, 33.42; H 3.63. Found: C 33.71; H 3.88.
J4,5b = 5.0 Hz, H-4), 3.45 (t, 1H, J5a,5b = 11.0 Hz, H-5a), 4.01
2,3,6,2′,3′,4′,6′-Hepta-O-acetyl-2S-acetyl cellobioside
(dd, 1H, H-5b), 4.52 (d, 1H, J1′ 2′ = 6.1 Hz, H-1′), 4.78 (t, 1H,
(9d). The title compound was prepared by using the same
J2′,3′ = 7.8 Hz, H-2′), 5.07 (t, 1H, J3′,4′ = 7.8 Hz, H-3′), 3.80
procedure as described for 9a. Treatment of 8d (1.88 g,
(ddd, 1H, J4′ ,5′ a = 8.6 Hz, J4′,5′ b = 5.2 Hz, H-4′), 3.38 (dd, 1H,
2.69 mmol) with potassium thioacetate (0.61 g, 5.38 mmol)
J 5’a,5’b = 11.6 Hz, H-5′a), 4.08 (dd, 1H, H-5′b), 2.34 (s, 3H, S-
and chromatography of the crude mixture (EtOAc/hexane,
Ac), 1.99, 2.00, 2.01, 2.02, 2.04 (5s, 15H, Ac). 13C NMR (100
20
1:9) produced pure 9d (1.08 g, 58%): mp 209–210 °C, [α]D
=
MHz, CDCl3): δ 20.61 (3 OAc), 20.70 (OAc), 20.76 (OAc),
30.83 (S-Ac), 61.68 (C-5′), 66.55 (C-2), 69.17 (C-2′), 70.42
(C-3), 70.60 (C-3′), 72.85 (C-4′), 74.30 (C-4), 80.52 (C-1),
99.63 (C-1’), 169.06, 169.48, 169.54, 169.72, and 169.90 (5
OAc). FABMS: m/z 551.0 (M+ + H, C22H30O14S, Calcd 550.5).
Anal. Calcd for C22H30O14S: C, 47.99; H, 5.49; S, 5.83. Found:
C, 48.20; H, 5.64; S, 5.71.
–14.3 (c 1, CHCl3); Rf = 0.54 (EtOAc/hexane, 3:2). 1H NMR
(400 MHz, CDCl3) δ 5.16 (d, 1H, J1,2 = 10.5 Hz, H-1), 3.76 (t,
1H, J2,3 = 8.6 Hz, H-2), 5.20 (t, 1H, J3,4 = 8.6 Hz, H-3), 5.02
(dd, 1H, J4,5 = 9.7 Hz, H-4), 3.70 (ddd, 1H, J4,5 = 9.7 Hz, J5,6a
=5.1 Hz, H-5), 4.33 (dd, J6a,6b = 12.3 Hz, J5,6a = 5.1 Hz, H-6a),
5.10 (t, 1H, H-6b), 4.46 (d, 1H, J1′,2′ = 8.2 Hz, H-1′), 4.88 (t,
1H, J2′,3′ = 8.0 Hz, H-2’), 4.07 (dd, 1H, J3’,4’ = 8.0 Hz, H-3’),
4.45 (t, 1H, J4′,5′ = 9.7 Hz, H-4’), 3.62 (ddd, 1H, J4’,5’ = 9.7 Hz,
J5′,6′a = 4.9 Hz, H-5′), 4.02 (dd, 1H, J6′a,6′b = 12.5 Hz, J5′,6′a = 4.9
Hz, H-6′a), 4.99 (t, 1H, H-6′b), 2.33 (s, 3H, S-Ac), 1.94, 1.97,
1.98, 1.99, 2.00, 2.06, 2.08 (7s, 21H, Ac). 13C NMR (100
MHz, CDCl3): δ 20.43 (6OAc), 20.70 (OAc), 30.71 (SAc),
61.81 (C-5′), 61.95 (C-5), 68.17 (C-2), 69.49 (C-2′), 71.72
(C-3), 72.11 (C-3′), 73.02 (C-4′), 73.63 (C-4), 75.97 (C-6′),
77.31 (C-6), 80.18 (C-1), 100.54 (C-1′), 168.82, 169.13,
169.36, 169.42, 170.00, 170.05, 170.29 (7OAc). CIMS: m/z
695.1 (MH+, C28H38O18S, Calcd 694.6). Anal. Calcd for
C28H38O18S: C, 48.41; H, 5.51; S, 4.62. Found: C, 48.43; H,
5.65; S, 4.64.
1-(Thiomethylmercuric)-β-D-xylobioside (5). The title
compound was prepared by using the same procedure as de-
scribed for 1. Treatment of thioacetate 9c (0.26 g, 0.47 mmol)
with NaOMe (0.5 M, 1.5 mL) was followed by treatment with
methylmercury(II)chloride (0.12 g, 0.48 mmol), which, after
chromatography of the crude material on silica gel (MeOH/
CHCl3, 1:9) and lyophylization, produced 0.15 g (65%) of
pure 5: [α]D20 = –24.6° (c 1, MeOH); Rf = 0.38 (1:3, MeOH-
CHCl3). 1H NMR (400 MHz, D2O): δ 4.81 (d, 1H, J1,2 = 9.2 Hz,
H-1), 3.26 (t, 1H, J2,3 = 9.0 Hz, H-2), 3.33 (t, 1H, J3,4 = 9.0 Hz,
H-3), 3.47 (ddd, 1H, J4,5a = 9.7 Hz, J4,5b = 5.5 Hz, H-4), 3.08 (t,
1H, J5a,5b = 11.5 Hz, H-5a), 3.95 (dd, 1H, H-5b), 4.29 (d, 1H,
J
1′,2′ = 7.7 Hz, H-1′), 3.14 (t, 1H, J2′,3′ = 7.6 Hz, H-2′), 3.22 (t,
2-(Thiomethylmercuric)-β-D-cellobioside (7). The title
compound was prepared by using the same procedure as de-
scribed for 1. Treatment of thioacetate 9d (0.49 g, 0.72 mmol)
with NaOMe (0.5 M, 5.0 mL) was followed by treatment with
methylmercury(II)chloride (0.19 g, 5.0 mmol), which, after
chromatography of the crude material on silica gel (MeOH/
CHCl3, 1:9) and crystallization from MeOH, produced 0.41 g
(67%) of pure 7: mp 159–162 °C (decomp.); [α]D20 = 23.8 (c 1,
1H, J3’,4’ = 7.6 Hz, H-3′), 3.64 (ddd, 1H, J4′,5a′ = 9.7 Hz, J4′,5′b
=
5.3 Hz, H-4′), 3.03 (t, 1H, J5′a,5′b = 11.5 Hz, H-5′a), 3.81 (dd,
1H, H-5′b), 0.63 (s, 3H, CH3). 13C NMR (100 MHz, D2O):
δ 12.44 (CH3), 67.89 (C-5’), 69.71 (C-5), 71.87 (C-2), 75.45
(C-2’), 77.90 (C-3), 78.30 (C-3’), 79.21 (C-4′), 80.93 (C-4),
86.00 (C-1), 104.47 (C-1′). FABMS: m/z 512.9 (M+ + H,
C11H20HgO8S, Calcd 513.1). Anal. Calcd for C11H20HgO8S: C,
25.76; H 3.93. Found: C 25.64; H 4.22.
1
DMSO); Rf = 0.62 (1:1 MeOH-CHCl3). H NMR (400 MHz,
D2O): δ 4.86 (d, 1H, J1,2 = 9.3 Hz, H-1), 3.05 (t, 1H, J2,3 = 8.8
Hz, H-2), 3.38 (t, 1H, J3,4 = 8.8 Hz, H-3), 3.60 (t, 1H, J4,5 = 7.3
Hz, H-4), 3.41 (ddd, 1H, J4,5 = 7.3 Hz, J5,6a = 6.0 Hz, H-5), 3.55
(dd, 1H, J6a,6b = 12.2 Hz, J5,6a = 6.0 Hz, H-6a), 3.76 (t, 1H,
1-(Thiophenylmercuric)-β-D-xylobioside (6). The title
compound was prepared by using the same procedure as de-
scribed for 1. Treatment of thioacetate 9c (0.26 g, 0.47 mmol)
with NaOMe (0.5 M, 1.5 mL) was followed by treatment with
phenylmercury(II)chloride (0.15 g, 0.48 mmol), which, after
chromatography of the crude material on silica gel (MeOH/
CHCl3, 1:9) and crystallization from MeOH, produced 0.15 g
H-6b), 4.31 (d, 1H, J1′,2′ = 7.7 Hz, H-1′), 3.12 (t, 1H, J2′,3′
8.3 Hz, H-2′), 3.31 (t, J3′,4′ = 8.3 Hz, H-3′), 3.47 (t, 1H, J4′,5′
=
=
9.2 Hz, H-4′), 3.29 (ddd, 1H, J4′,5′ = 9.2 Hz, J5′,6a′ = 5.2 Hz,
H-5′), 3.52 (dd, 1H, J6′a,6′b = 12.7 Hz, J5′,6′a = 5.2 Hz, H-6′a),
3.74 (t, 1H, H-6′b), 0.61 (s, 3H, CH3). 13C NMR (100 MHz,
D2O): δ 12.57 (CH3), 63.14 (C-5′), 63.38 (C-5), 72.24 (C-2),
75.91 (C-2′), 78.29 (C-3), 78.42 (C-3′), 78.72 (C-4′), 80.85
(C-4), 81.61 (C-6′), 81.73 (C-6), 85.16 (C-1), 105.18 (C-1′).
FABMS: m/z 573.2 (M+ + H, C13H24O10S, Calcd 572.9). Anal.
Calcd for C13H24O10S: C, 27.25; H, 4.22. Found: C, 27.12; H,
4.33.
20
(51%) of pure 6: mp 174–175 °C (decomp.); [α]D = –12.9°
1
(c 1, MeOH); Rf = 0.47 (MeOH-CHCl3, 1:3). H NMR (400
MHz, D2O) d 4.76 (1H, J1,2 = 9.3 Hz, H-1), 3.21 (t, 1H, J2,3
=
9.0 Hz, H-2), 3.31 (t, 1H, J3,4 = 9.0 Hz, H-3), 3.43 (ddd, 1H,
J4,5a = 9.6 Hz, J4,5b = 5.6 Hz, H-4), 3.07 (t, 1H, J5a,5b =11.5 Hz,
H-5a), 3.93 (dd, 1H, H-5b), 4.24 (d, 1H, J 1′,2′ = 7.8 Hz, H-1′),
3.13 (t, 1H, J2′,3′ = 8.0 Hz, H-2′), 3.19 (t, 1H, J3′,4′ = 8.0 Hz,
H-3′), 3.61 (ddd, 1H, J4′,5′a = 9.8 Hz, J4′,5′b = 5.5 Hz, H-4′), 3.03
(t, 1H, J5′a,5′b = 11.5 Hz, H-5′a), 3.77 (dd, 1H, H-5′b), 7.14-7.26 Crystallographic
(m, 5H, aromatic protons). 13C NMR (100 MHz, D2O): δ 67.74
1-(Thiomethylmercuric)-β-D-xyloside (3) was recrystal-
(C-5′), 69.67 (C-5), 71.69 (C-2), 75.27 (C-2′), 77.73 (C-3), lized from methanol. Intensity data from clear colorless trans-
78.12 (C-3′), 79.03 (C-4′), 80.73 (C-4), 85.86 (C-1), 104.30 parent plate crystals were collected at 293(2) K on a Nonius
(C-1′), 131.26, 131.47, 139.21 (aromatic carbons). FABMS: KappaCCD diffractometer. Table 4 provides crystallographic
Belakhov et al. / Thiomercuric Derivatives of Sugars